19 results
8-K/A
CMMB
Chemomab Therapeutics Ltd
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
becomes subject to integrity and oversight agreements to resolve allegations of non-compliance, contractual damages, reputational harm, diminished … and penalties, litigation, and reputational harm in connection with its European activities. Further, the United Kingdom’s decision to leave the EU, often
424B3
62i42l371nhpj52kmx6
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
uqozl2
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
7dgeuo n4
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
10-K
ggp7mnhykm vxm
17 Mar 20
Annual report
5:27pm
20-F/A
8rbiucbg7w2 m34nzl
24 Apr 19
Annual report (foreign) (amended)
5:19pm
424B4
59zag
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
xkegp96ze08 tk
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
kywvlrr0cqxl2rk
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
qa9f8m6p8 bqmvl3u
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
abep0d27e3xmc
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
4ysn8u856ysy0e2t
27 Nov 18
Draft registration statement (amended)
12:00am
DRS
ff83w0d
28 Sep 18
Draft registration statement
12:00am
- Prev
- 1
- Next